{"id":"W4404555543","doi":"10.1111/myc.70001","title":"The In Vitro Activity of Rezafungin Against Uncommon Species of <i>Candida</i>","year":2024,"lang":"en","type":"article","venue":"Mycoses","topic":"Antifungal resistance and susceptibility","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Genentech; U.S. Food and Drug Administration; National Institutes of Health; Astellas Pharma; Basilea Pharmaceutica; TenNor Therapeutics; Carnegie Mellon University; Astellas Foundation for Research on Metabolic Disorders; Ohio State University; Nabriva Therapeutics; Pfizer; Melinta Therapeutics; Entasis Therapeutics; Wockhardt; Mundipharma International; Zoetis; Menarini Group; McGill University; Roche; Cidara Therapeutics; Medpace; Harvard University; Meiji Seika Pharma; Shionogi; National Cancer Institute; Gilead Sciences; GlaxoSmithKline; Dr. Falk Pharma","keywords":"Candida auris; Echinocandin; Broth microdilution; Fluconazole; Echinocandins; Microbiology; Candida dubliniensis; Biology; Minimum inhibitory concentration; Antifungal; Corpus albicans; Caspofungin; Antimicrobial","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005075587,0.0006287975,0.0003880774,0.0004910094,0.0001848501,0.0003981932,0.0003963397,0.0005287719,0.001716721],"category_scores_gemma":[0.0006171648,0.0001566128,0.0004828269,0.0003986523,0.0001428827,0.0002038164,0.0002236758,0.0003800662,0.0005337048],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002896136,"about_ca_system_score_gemma":0.0002654279,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002602871,"about_ca_topic_score_gemma":0.002745345,"domain_scores_codex":[0.9993661,0.0001337011,0.000105054,0.0001060456,0.00018712,0.0001019465],"domain_scores_gemma":[0.999422,0.0002077336,0.0001385817,0.0000574944,0.0001316704,0.0000426128],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.001019389,0.0003995418,0.01128866,0.0006397325,0.0001191706,0.0002275874,0.00006950058,0.0009652914,0.9689277,0.00004461615,0.0003396926,0.01595908],"study_design_scores_gemma":[0.00008825587,0.008478456,0.06191986,0.00013432,0.0002252521,0.00197038,0.00006758312,0.001534221,0.9215627,0.00003618679,0.003956317,0.00002655457],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9807341,0.01277516,0.001054109,0.0001109697,0.000061091,0.00009774928,0.001721052,0.00003755758,0.003408116],"genre_scores_gemma":[0.9921882,0.002403366,0.002075414,0.00006590578,0.00003751347,0.0000286037,0.002520309,0.000009032065,0.0006717441],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002602871,"threshold_uncertainty_score":0.005743027,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01588609272568805,"score_gpt":0.2744423396442611,"score_spread":0.2585562469185731,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}